Literature DB >> 4839055

Identification of two distinct heparin cofactors in human plasma. Separation and partial purification.

G F Briginshaw, J N Shanberge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4839055     DOI: 10.1016/0003-9861(74)90354-3

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


× No keyword cloud information.
  7 in total

1.  Inhibition of chymotrypsin by heparin cofactor II.

Authors:  F C Church; C M Noyes; M J Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

2.  Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

Authors:  D M Tollefsen; C A Pestka
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.

Authors:  M J Griffith
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity.

Authors:  A Ceriello; E Marchi; M Barbanti; M R Milani; D Giugliano; A Quatraro; P Lefebvre
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

5.  Detection of a new heparin-dependent inhibitor of thrombin in human plasma.

Authors:  D M Tollefsen; M K Blank
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

Review 6.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

7.  Heparin Cofactor II: A Novel Plausible Link of Obesity and Diabetes with Thrombosis.

Authors:  Yutaka Hasegawa; Yasushi Ishigaki
Journal:  J Atheroscler Thromb       Date:  2017-08-10       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.